Oliver Eng

Title(s)Associate Clinical Professor, Surgery
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Adoption of cytoreductive surgery in the management of peritoneal malignancies-Global trends. J Surg Oncol. 2023 Nov; 128(6):1021-1031. Sedighim S, Khan A, Li AY, Tajik F, Radhakrishnan VK, Eng O, Turaga K, Senthil M. PMID: 37818906.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Early Integrated Palliative Care Within a Surgical Oncology Clinic. JAMA Netw Open. 2023 Nov 01; 6(11):e2341928. Bansal VV, Kim D, Reddy B, Witmer HDD, Dhiman A, Godley FA, Ong CT, Clark S, Ulrich L, Polite B, Shergill A, Malec M, Eng OS, Tun S, Turaga KK. PMID: 37934497; PMCID: PMC10630898.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. ASO Visual Abstract: Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2023 Oct 09. Vierra M, Bansal VV, Morgan RB, Witmer HDD, Reddy B, Dhiman A, Godley FA, Ong CT, Belmont E, Polite B, Shergill A, Turaga KK, Eng OS. PMID: 37814180.
      View in: PubMed   Mentions:    Fields:    
    4. ASO Author Reflections: Fragmented Care in Patients with Peritoneal Metastases. Ann Surg Oncol. 2023 Oct 06. Vierra M, Bansal VV, Shergill A, Turaga KK, Eng OS. PMID: 37803088.
      View in: PubMed   Mentions:    Fields:    
    5. Primary sarcoma of the liver: A nationwide analysis of a rare mesenchymal tumor. J Surg Oncol. 2023 Oct 05. Finney N, Tran T, Hasjim BJ, Jakowatz J, Chiao E, Eng O, Wolf R, Jutric Z, Yamamoto M, Tran TB. PMID: 37796036.
      View in: PubMed   Mentions:    Fields:    
    6. Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2023 Sep 22. Vierra M, Bansal VV, Morgan RB, Witmer HDD, Reddy B, Dhiman A, Godley FA, Ong CT, Belmont E, Polite B, Shergill A, Turaga KK, Eng OS. PMID: 37737968.
      View in: PubMed   Mentions:    Fields:    
    7. Design and Implementation of a Learner-Centered Self-Paced Peritoneal Oncology Education Program. Ann Surg Oncol. 2023 Nov; 30(12):6983-6986. Bansal VV, Witmer HDD, Lam A, Morgan RB, Godley F, Ong CT, Dhiman A, Eng OS, Turaga KK. PMID: 37632574.
      View in: PubMed   Mentions:    Fields:    
    8. Doublet vs. Triplet Systemic Chemotherapy for High Grade Appendiceal Adenocarcinoma with Peritoneal Metastases. J Gastrointest Surg. 2023 Jun 12. Morgan RB, Dhiman A, Kim AC, Shergill A, Polite B, Turaga KK, Eng OS. PMID: 37308734.
      View in: PubMed   Mentions:    Fields:    
    9. Readmission and Disposition in Patients With Malignant Bowel Obstructions Following Gastrostomy Tube. Am Surg. 2023 May 31; 31348231180915. Yu J, Sullivan BG, Nguyen NT, Hohmann SF, Harris AH, Micic D, Turaga KK, Senthil M, Eng OS. PMID: 37257144.
      View in: PubMed   Mentions:    Fields:    
    10. A Novel Assessment of Metabolic Pathways in Peritoneal Metastases from Low-Grade Appendiceal Mucinous Neoplasms. Ann Surg Oncol. 2023 Aug; 30(8):5132-5141. Hanse EA, Wang T, Tifrea D, Senthil M, Kim AC, Kong M, Eng OS. PMID: 37149550.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 May; 30(5):3123-3124. Peerenboom R, Dhiman A, Witmer HDD, Spurr LF, Polite B, Eng OS, Shergill A, Turaga KK. PMID: 36641511.
      View in: PubMed   Mentions:    Fields:    
    12. Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation. Cancer. 2023 07 15; 129(14):2152-2160. Berger Y, Gadiraju M, Dhiman A, Gilliam K, Opalecky B, Chen H, Helgeson M, Eng OS, Husain AN, Drazer MW, Kindler HL, Churpek JE, Turaga KK. PMID: 37042570.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy postoperative symptomatology: palliative care impact. BMJ Support Palliat Care. 2023 Apr 06. Sneider AP, Dhiman A, Morgan R, Tun S, Turaga KK, Eng OS. PMID: 37024290.
      View in: PubMed   Mentions:    Fields:    
    14. Role of Tumor-informed Personalized ctDNA Assay in Informing Recurrence in Patients with Peritoneal Metastases from Colorectal and High-grade Appendix Cancer Undergoing Curative Intent Surgery. Ann Surg. 2023 Mar 30. Dhiman A, Kothary V, Witmer HDD, Bregio C, Sood D, Ong CT, Polite B, Eng OS, Shergill A, Turaga KK. PMID: 36994703.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Improving online resources for cytoreductive surgery and HIPEC by engaging patients. J Surg Oncol. 2023 07; 128(1):175-176. Rouhi AD, Muhammad HA, Lee B, Eng OS. PMID: 36971652.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 May; 30(5):3114-3122. Peerenboom R, Dhiman A, Witmer HDD, Spurr LF, Polite B, Eng OS, Shergill A, Turaga KK. PMID: 36637640.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J Surg Oncol. 2023 Apr; 127(5):831-840. Morgan RB, Dhiman A, Sood D, Ong CT, Wu X, Shergill A, Polite B, Turaga KK, Eng OS. PMID: 36636792.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. ASO Visual Abstract: Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2023 Jan; 30(1):425. Ong CT, Dhiman A, Smith A, Jose A, Kallakuri P, Belanski J, Sood D, Witmer HDD, Morgan RB, Turaga KK, Eng OS. PMID: 36071340.
      View in: PubMed   Mentions:    Fields:    
    19. Palliative Care and Characterization of Symptoms in Patients Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2023 03; 283:1154-1160. Sneider AP, Dhiman A, Sood D, Ong C, Tun S, Malec M, Levine S, Turaga KK, Eng OS. PMID: 36915007.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 Dec; 29(Suppl 3):616-617. Dhiman A, Vining CC, Witmer HDD, Sood D, Shergill A, Kindler H, Roggin KK, Posner MC, Ahmed OS, Liauw S, Pitroda S, Liao CY, Karrison T, Weichselbaum R, Polite B, Eng OS, Catenacci DVT, Turaga KK. PMID: 35930113.
      View in: PubMed   Mentions: 1     Fields:    Translation:CTClinical Trials
    21. Medicare Advantage: A Disadvantage for Complex Cancer Surgery Patients. J Clin Oncol. 2023 02 20; 41(6):1239-1249. Raoof M, Ituarte PHG, Haye S, Jacobson G, Sullivan KM, Eng O, Kim J, Fong Y. PMID: 36356283.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. The role of cytoreductive surgery and intraperitoneal chemotherapy in gastric cancer. Clin Adv Hematol Oncol. 2022 Nov; 20(11):673-682. Young S, Ostowari A, Yu J, Eng OS, Dayyani F, Senthil M. PMID: 36331405.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Disparities in access to care among patients with appendiceal or colorectal cancer and peritoneal metastases: A medicare insurance-based study in the United States. Front Oncol. 2022; 12:970237. Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Eng OS, Monson JRT, Ruff SM, Kasumova GG, Adam MO, Obeng-Gyasi S, Pawlik TM, Kim AC. PMID: 36387266; PMCID: PMC9659914.
      View in: PubMed   Mentions: 3  
    24. A population-based evaluation of tunica vaginalis mesothelioma: An analysis of the National Cancer Database. Urol Oncol. 2023 01; 41(1):52.e11-52.e20. Witmer HDD, Dhiman A, Giurcanu M, Eng OS, Eggener S, Kindler HL, Turaga KK. PMID: 36319552.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. ASO Author Reflections: The Current Insurance Authorization Process and Future Directions for Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2022 Oct 02. Ong CT, Eng OS. PMID: 36183018.
      View in: PubMed   Mentions: 1     Fields:    
    26. Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2022 Sep 16. Ong CT, Dhiman A, Smith A, Jose A, Kallakuri P, Belanski J, Sood D, Witmer HDD, Morgan RB, Turaga KK, Eng OS. PMID: 36112250.
      View in: PubMed   Mentions: 2     Fields:    
    27. Survival in Total Preoperative vs. Perioperative Chemotherapy for Patients with Metastatic High-Grade Appendiceal Adenocarcinoma Undergoing CRS/HIPEC. J Gastrointest Surg. 2022 12; 26(12):2591-2594. Morgan RB, Yan A, Dhiman A, Shergill A, Polite B, Turaga KK, Eng OS. PMID: 35879590.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. The Impact of COVID-19-Related Delays on Surgical Management of Peritoneal Surface Malignancies. Ann Surg Oncol. 2022 09; 29(9):5377-5378. Sood D, Dhiman A, Ong CT, Liu AY, Belanski J, Turaga KK, Eng OS. PMID: 35503391; PMCID: PMC9063612.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic Review. JCO Precis Oncol. 2022 02; 6:e2100337. Hsu PJ, Singh K, Dhiman A, Witmer HDD, He C, Eng OS, Catenacci DVT, Posner MC, Turaga KK. PMID: 35188804; PMCID: PMC8984241.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 Jan 05. Dhiman A, Vining CC, Witmer HDD, Sood D, Shergill A, Kindler H, Roggin KK, Posner MC, Ahmed OS, Liauw S, Pitroda S, Liao CY, Karrison T, Weichselbaum R, Polite B, Eng OS, Catenacci DVT, Turaga KK. PMID: 34988836; PMCID: PMC8730296.
      View in: PubMed   Mentions:    Fields:    
    31. Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination. Am J Clin Oncol. 2022 01 01; 45(1):9-13. Vierra M, Dhiman A, Witmer HDD, Ulrich L, Hindi E, Fenton E, Shergill A, Polite B, Eng OS, Turaga KK. PMID: 34857698.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    32. Response to the Comment on "Cancer Surgery During COVID-19: How We Move Forward". Ann Surg. 2021 12 01; 274(6):e828-e829. Eng OS, Pawlik TM, Ejaz A. PMID: 33214441.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    33. Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative. J Surg Oncol. 2022 Mar; 125(4):560-563. Brajcich BC, Benson AB, Gantt G, Eng OS, Marsh RW, Mulcahy MF, Polite BN, Shogan BD, Yang AD, Merkow RP. PMID: 34820843; PMCID: PMC9015333.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient. J Gastrointest Surg. 2021 12; 25(12):3258-3264. White MG, Morgan RB, Drazer MW, Eng OS. PMID: 34506017; PMCID: PMC8665083.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    35. ASO Author Reflections: Disparities in Access to Cytoreductive Surgery. Ann Surg Oncol. 2021 11; 28(12):7807-7808. Goldberg EM, Eng OS. PMID: 34013481.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer. Ann Surg Oncol. 2021 Nov; 28(12):7795-7806. Goldberg EM, Berger Y, Sood D, Kurnit KC, Kim JS, Lee NK, Yamada SD, Turaga KK, Eng OS. PMID: 33959831; PMCID: PMC8530985.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC. Ann Surg Oncol. 2021 Nov; 28(12):6955-6964. Dhiman A, Fenton E, Whitridge J, Belanski J, Petersen W, Macaraeg S, Rangrass G, Shergill A, Micic D, Eng OS, Turaga K. PMID: 33954868.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Hyperthermic Intraperitoneal Chemotherapy: An Overview #412. J Palliat Med. 2021 04; 24(4):621-622. Morgan R, Tun S, Eng OS. PMID: 33797986.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy. Ann Surg Oncol. 2021 Aug; 28(8):4433-4443. Berger Y, Giurcanu M, Vining CC, Schuitevoerder D, Posner MC, Roggin KK, Polite BN, Liao CY, Eng OS, Catenacci DVT, Turaga KK. PMID: 33420565.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Response to Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy". Br J Cancer. 2021 03; 124(6):1179-1180. White MG, Eng OS. PMID: 33318658; PMCID: PMC7961136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325. Catenacci DVT, Moya S, Lomnicki S, Chase LM, Peterson BF, Reizine N, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Hogarth DK, Eng OS, Turaga K, Roggin K, Posner MC, Chang P, Narula S, Rampurwala M, Ji Y, Karrison T, Liao CY, Polite BN, Kindler HL. PMID: 33234578; PMCID: PMC7858231.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    42. A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surg Oncol. 2021 Jun; 37:101492. Wiseman JT, Abdel-Misih S, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Eng O, Fackche N, Greer J, Pawlik TM, Cloyd JM. PMID: 33465587.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. Br J Cancer. 2021 02; 124(3):564-566. White MG, Schulte JJ, Xue L, Berger Y, Schuitevoerder D, Vining CC, Kindler HL, Husain A, Turaga KK, Eng OS. PMID: 33100328; PMCID: PMC7851380.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    44. Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy. JCO Precis Oncol. 2020; 4. Reizine N, Peterson B, Moya S, Wang Y, Tan YCYH, Eng OS, Bilimoria M, Lengyel E, Turaga K, Catenacci DVT. PMID: 33215053; PMCID: PMC7670563.
      View in: PubMed   Mentions: 5     Fields:    
    45. Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-Grade Appendiceal Ex-Goblet Adenocarcinoma. Ann Surg Oncol. 2021 Mar; 28(3):1777-1785. Berger Y, Schuitevoerder D, Vining CC, Alpert L, Fenton E, Hindi E, Liao CY, Shergill A, Catenacci DVT, Polite BN, Eng OS, Turaga KK. PMID: 32892267.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Cancer Surgery During COVID-19: How We Move Forward. Ann Surg. 2020 08; 272(2):e94-e95. Eng OS, Pawlik TM, Ejaz A. PMID: 32675508; PMCID: PMC7268835.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    47. Apples to Oranges: Ethical Considerations in COVID-19 Surgical Recovery. Ann Surg. 2020 08; 272(2):e52. Eng OS, Tseng J, Ejaz A, Pawlik TM, Angelos P. PMID: 32675494; PMCID: PMC7268873.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    48. Benchmarking Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement. Ann Surg Oncol. 2020 Dec; 27(13):5039-5046. Liu JB, Schuitevoerder D, Vining CC, Berger Y, Turaga KK, Eng OS. PMID: 32729047.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol. 2020 Dec; 27(13):4980-4995. Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA. PMID: 32696303; PMCID: PMC7988818.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    50. HIPEC with cisplatin in a patient with a prior hypersensitivity reaction to systemic oxaliplatin. Basic Clin Pharmacol Toxicol. 2020 Dec; 127(6):551-553. Morgan R, Parsad S, Turaga KK, Eng OS. PMID: 32623784.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Assessment of the Surgical Workforce Pertaining to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United States. Ann Surg Oncol. 2020 09; 27(9):3097-3102. Schuitevoerder D, Sherman SK, Izquierdo FJ, Eng OS, Turaga KK. PMID: 32632884.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    52. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. J Surg Oncol. 2020 Oct; 122(5):980-985. Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston FM, Dineen S, Powers B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Walle KV, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M. PMID: 32627199.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    53. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve. J Surg Oncol. 2020 Jul; 122(1):85-95. Vining CC, Izquierdo F, Eng OS, Turaga KK. PMID: 32436240.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):911-915. Vining CC, Eng OS, Hogg ME, Schuitevoerder D, Silverman RS, Yao KA, Winchester DJ, Roggin KK, Talamonti MS, Posner MC, Turaga KK, Tseng J. PMID: 32424589; PMCID: PMC7233675.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCellsPHPublic Health
    55. The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Ann Surg Oncol. 2020 Jun; 27(6):1743-1752. Chicago Consensus Working Group. PMID: 32285276.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Ann Surg Oncol. 2020 Jun; 27(6):1753-1760. Chicago Consensus Working Group. PMID: 32285275.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    57. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors. Ann Surg Oncol. 2020 Jun; 27(6):1788-1792. Chicago Consensus Working Group. PMID: 32285274.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma. Ann Surg Oncol. 2020 Jun; 27(6):1774-1779. Chicago Consensus Working Group. PMID: 32285273.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    59. The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Ann Surg Oncol. 2020 Jun; 27(6):1798-1804. Chicago Consensus Working Group. PMID: 32285272.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    60. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Ann Surg Oncol. 2020 Jun; 27(6):1780-1787. Chicago Consensus Working Group. PMID: 32285271.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. Ann Surg Oncol. 2020 Jun; 27(6):1761-1767. Chicago Consensus Working Group. PMID: 32285270.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    62. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Ann Surg Oncol. 2020 Jun; 27(6):1768-1773. Chicago Consensus Working Group. PMID: 32285269.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. Ann Surg Oncol. 2020 Jun; 27(6):1793-1797. Chicago Consensus Working Group. PMID: 32285268.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. The Chicago Consensus on Peritoneal Surface Malignancies: Methodology. Ann Surg Oncol. 2020 Jun; 27(6):1741-1742. Chicago Consensus Working Group. PMID: 32285267.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer. 2020 06 01; 126(11):2547-2552. Chicago Consensus Working Group. PMID: 32282077.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    66. The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases. Cancer. 2020 06 01; 126(11):2541-2546. Chicago Consensus Working Group. PMID: 32282074.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    67. The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. Cancer. 2020 06 01; 126(11):2525-2533. Chicago Consensus Working Group. PMID: 32282073.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    68. The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. Cancer. 2020 06 01; 126(11):2566-2570. Chicago Consensus Working Group. PMID: 32282072.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. Cancer. 2020 06 01; 126(11):2534-2540. Chicago Consensus Working Group. PMID: 32282070.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    70. The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors. Cancer. 2020 06 01; 126(11):2561-2565. Chicago Consensus Working Group. PMID: 32282069.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms. Cancer. 2020 06 01; 126(11):2553-2560. Chicago Consensus Working Group. PMID: 32282068.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. The Chicago Consensus on peritoneal surface malignancies: Standards. Cancer. 2020 06 01; 126(11):2516-2524. Chicago Consensus Working Group. PMID: 32282066.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. The Chicago Consensus on peritoneal surface malignancies: Methodology. Cancer. 2020 06 01; 126(11):2513-2515. Chicago Consensus Working Group. PMID: 32282063.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. Cancer. 2020 06 01; 126(11):2571-2576. Chicago Consensus Working Group. PMID: 32282059.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. Int J Hyperthermia. 2020; 37(1):1182-1188. Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Eng O, Johnston FM, Greer J, Grotz TE. PMID: 33040617.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    76. Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin. Ann Surg Oncol. 2020 03; 27(3):630-631. Tun S, Eng OS, Malec M. PMID: 31848812.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. The Association of Tumor Laterality and Survival After Cytoreduction for Colorectal Carcinomatosis. J Surg Res. 2020 04; 248:20-27. Blakely AM, Lafaro KJ, Eng OS, Ituarte PHG, Fakih M, Lee B, Raoof M. PMID: 31841733.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    78. Peritoneal Metastases in Colorectal Cancer: Biology and Barriers. J Gastrointest Surg. 2020 03; 24(3):720-727. Xue L, Hyman NH, Turaga KK, Eng OS. PMID: 31745890.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    79. Health-related quality of life and oncologic outcomes after surgery in older adults with colorectal cancer. Support Care Cancer. 2020 Jun; 28(6):2857-2865. Blakely AM, Chanson D, Wong FL, Eng OS, Sentovich SM, Melstrom KA, Lai LL, Fong Y, Sun V. PMID: 31729565; PMCID: PMC7700837.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. Getting to the Root of the Problem. Gastroenterology. 2020 04; 158(5):1229-1231. Wang J, Eng OS, Micic D. PMID: 31560904.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. J Gastrointest Surg. 2020 01; 24(1):155-164. Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH. PMID: 31428960.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    82. Implementation of bundled care to reduce surgical site infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2019 11; 120(6):1044-1045. Poli EC, Millis AM, Berger Y, Sherman SK, Schuitevoerder D, Dahdaleh F, Kamm A, Eng OS, Turaga KK. PMID: 31424562.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    83. A prognostic nomogram for patients with resected fibrolamellar hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2019 Aug; 8(4):338-344. Lafaro KJ, Eng OS, Raoof M, Ituarte P, Warner SG, Singh G, Fong Y, Melstrom LG. PMID: 31489303; PMCID: PMC6700009.
      View in: PubMed   Mentions: 3  
    84. Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience. HPB (Oxford). 2019 11; 21(11):1520-1526. Melstrom LG, Eng OS, Raoof M, Singh G, Fong Y, Latorre K, Choi GH, Salem R, Bentrem DJ, Lewandowski R, Makris E, Poultsides G, Dhar VK, Chadalavada S, Shah SA, Johnson AC, Sekhar A, Kies D, Maithel SK, Rocha F, Alseidi A, Hagendoorn J, Borel Rinkes IHM, Fisher AV, Ronnekleiv-Kelly S, Weber SM, Winslow ER, Abbott DE. PMID: 31005493.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    85. Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer. J Surg Oncol. 2019 Apr; 119(5):613-615. Eng OS, Turaga KK. PMID: 30852849.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    86. Disparities in survival after trimodality therapy for esophageal adenocarcinoma. Dis Esophagus. 2018 Sep 01; 31(9). Eng OS, Nelson RA, Konstantinidis I, Chao J, Erhunmwunsee L, Raz DJ, Kim JY. PMID: 29534155.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    87. Academic productivity in surgical oncology: Where is the bar set for those training the next generation? J Surg Oncol. 2018 Sep; 118(3):397-402. LaRocca CJ, Wong P, Eng OS, Raoof M, Warner SG, Melstrom LG. PMID: 30125359; PMCID: PMC6160329.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    88. Hypothermia Is Associated with Surgical Site Infection in Cytoreductive Surgery with Hyperthermic Intra-Peritoneal Chemotherapy. Surg Infect (Larchmt). 2018 Aug/Sep; 19(6):618-621. Eng OS, Raoof M, O'Leary MP, Lew MW, Wakabayashi MT, Paz IB, Melstrom LG, Lee B. PMID: 30044187.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    89. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer. J Surg Oncol. 2018 Jul; 118(1):121-126. Eng OS, Raoof M, Blakely AM, Yu X, Lee SJ, Han ES, Wakabayashi MT, Yuh B, Lee B, Dellinger TH. PMID: 29878375.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    90. Fluids in abdominal surgery: what is the goal? Hepatobiliary Surg Nutr. 2018 Jun; 7(3):227-228. Eng OS. PMID: 30046582; PMCID: PMC6036067.
      View in: PubMed   Mentions: 1  
    91. Quality of Life, Symptoms, and Self-Management Strategies After Gastroesophageal Cancer Surgery. J Pain Symptom Manage. 2018 08; 56(2):e4-e8. Eng OS, Kim JY, Ruel N, Raz DJ, Erhunmwunsee L, Melstrom LG, Chao J, Woo Y, Kim J, Sun V. PMID: 29753100; PMCID: PMC6659401.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    92. Robotic total pancreatectomy with splenectomy: technique and outcomes. Surg Endosc. 2018 08; 32(8):3691-3696. Konstantinidis IT, Jutric Z, Eng OS, Warner SG, Melstrom LG, Fong Y, Lee B, Singh G. PMID: 29273875; PMCID: PMC6014914.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    93. Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy. JAMA Surg. 2017 Dec 01; 152(12):1156-1160. Eng OS, Dumitra S, O'Leary M, Raoof M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B. PMID: 28832866; PMCID: PMC5831441.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    94. Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2017 Sep; 24(9):2707-2711. Eng OS, Dumitra S, O'Leary M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Benjamin Paz I, Singh G, Lee B. PMID: 28560593.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    95. Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique. Gland Surg. 2016 Dec; 5(6):571-575. Eng OS, Grant SB, Weissler J, Simon M, Roychowdhury S, Davidov T, Trooskin SZ. PMID: 28149802; PMCID: PMC5233840.
      View in: PubMed   Mentions: 1  
    96. Fluid administration and morbidity in transhiatal esophagectomy. J Surg Res. 2016 Jan; 200(1):91-7. Eng OS, Arlow RL, Moore D, Chen C, Langenfeld JE, August DA, Carpizo DR. PMID: 26319974; PMCID: PMC4914131.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    97. A sensitive liquid chromatography-mass spectrometry bioanalytical assay for a novel anticancer candidate--ZMC1. Biomed Chromatogr. 2015 Nov; 29(11):1708-14. Lin H, Yu X, Eng OS, Buckley B, Kong AN, Bertino JR, Carpizo DR, Gounder MK. PMID: 25944179; PMCID: PMC5481844.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    98. The relationship of perioperative fluid administration to outcomes in colorectal and pancreatic surgery: a review of the literature. J Surg Oncol. 2015 Mar 15; 111(4):472-7. Eng OS, Melstrom LG, Carpizo DR. PMID: 25643938; PMCID: PMC4499324.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    99. Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience. J Surg Oncol. 2015 Mar 15; 111(4):410-3. Eng OS, Tsang AT, Moore D, Chen C, Narayanan S, Gannon CJ, August DA, Carpizo DR, Melstrom LG. PMID: 25557924; PMCID: PMC4499323.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    100. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology. Ann Surg Oncol. 2015 May; 22(5):1527-32. Macias CA, Arumugam D, Arlow RL, Eng OS, Lu SE, Javidian P, Davidov T, Trooskin SZ. PMID: 25388058.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    101. Does nodule size predict compressive symptoms in patients with thyroid nodules? Gland Surg. 2014 Nov; 3(4):232-6. Eng OS, Potdevin L, Davidov T, Lu SE, Chen C, Trooskin SZ. PMID: 25493254; PMCID: PMC4244507.
      View in: PubMed   Mentions: 9  
    102. Diagnosing thyroid lymphoma: steroid administration may result in rapid improvement of dyspnea : a report of two cases. Int J Endocrinol Metab. 2014 Jan; 12(1):e11463. Eng OS, Lesniak S, Davidov T, Trooskin SZ. PMID: 24696693; PMCID: PMC3969003.
      View in: PubMed   Mentions: 2  
    103. Repair of a post-hepatectomy posterior sectoral duct injury secondary to anomalous bile duct anatomy using a novel combined surgical-interventional radiologic approach. Case Rep Surg. 2013; 2013:202315. Shanker BA, Eng OS, Gendel V, Nosher J, Carpizo DR. PMID: 24159406; PMCID: PMC3789281.
      View in: PubMed   Mentions: 1  
    104. CASE REPORT Successful Treatment of a Rare Massive Dabska Tumor. Eplasty. 2013; 13:e46. Eng OS, Borah GL, Gannon CJ. PMID: 24058717; PMCID: PMC3776570.
      View in: PubMed   Mentions:
    105. Intraoperative fluid administration is associated with perioperative outcomes in pancreaticoduodenectomy: a single center retrospective analysis. J Surg Oncol. 2013 Sep; 108(4):242-7. Eng OS, Goswami J, Moore D, Chen C, Gannon CJ, August DA, Carpizo DR. PMID: 23907788; PMCID: PMC5481842.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    106. Safety and efficacy of LigaSure usage in pancreaticoduodenectomy. HPB (Oxford). 2013 Oct; 15(10):747-52. Eng OS, Goswami J, Moore D, Chen C, Brumbaugh J, Gannon CJ, August DA, Carpizo DR. PMID: 23782268; PMCID: PMC3791113.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    107. Is one benign fine needle aspiration enough? Ann Surg Oncol. 2012 May; 19(5):1472-6. Chernyavsky VS, Shanker BA, Davidov T, Crystal JS, Eng O, Ibrahim K, Kwong J, Trooskin SZ. PMID: 21969084.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    108. Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy. Surgery. 2010 Dec; 148(6):1294-9; discussion 1299-301. Davidov T, Trooskin SZ, Shanker BA, Yip D, Eng O, Crystal J, Hu J, Chernyavsky VS, Deen MF, May M, Artymyshyn RL. PMID: 21134564.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    109. Interpulse interval modulation by echolocating big brown bats (Eptesicus fuscus) in different densities of obstacle clutter. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2009 Jun; 195(6):603-17. Petrites AE, Eng OS, Mowlds DS, Simmons JA, DeLong CM. PMID: 19322570.
      View in: PubMed   Mentions: 37     Fields:    Translation:Animals
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Oliver's Networks
    Concepts (240)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California